Cheap Drugs Threaten Free Trade Agreement

Protesters in Delhi delivered coffins to the EU delegation, claiming a new EU-India trade agreement threatens access to affordable generic medicines, crucial for millions in developing countries. The EU representative declined to comment, while activists argue the deal prioritizes pharmaceutical profits over lives. India's role as a major supplier of generic drugs is highlighted, with concerns about the impact on HIV patients who rely on these affordable medicines. Despite EU assurances, activists continue global campaigns, viewing the agreement as a threat to public health.

What are the potential consequences for individuals if Indian courts start prosecuting generic drug companies?

In what ways do activists plan to continue their campaign regarding the protection of cheap generic drugs?